NCT06245122 2026-04-06
A Study of CS23546 in Subjects With Advanced Tumors
Chipscreen Biosciences, Ltd.
Phase 1 Recruiting
Chipscreen Biosciences, Ltd.
ModeX Therapeutics, An OPKO Health Company
Shanghai Institute Of Biological Products
Advenchen Laboratories, LLC